Brain ischemia is the most common cause of invalidity in adults and consequently of death throughout the world. This phenomenon occurs when blood flow is reduced or interrupted in the various brain districts leading to oxygen and glucose deprivation (OGD), which by triggering an intricate succession of biochemical plus molecular events such as an increased production of oxidized and misfolded proteins together with the breakdown of cellular integrity lead to cell death. Despite the lack of information on the triggering mechanisms of ischemic insults, numerous studies are pointing to excitotoxic glutamatergic receptor (GluR) neuronal signaling processes as key mediators of these events. Indeed, from cultured neurons of OGD-related global cerebral ischemia, it seems that this protocol causes a rapid internalization of α amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs) thereby suggesting these receptor subtypes as critical components of neuronal death. In particular it seems that OGD-dependent neuronal ischemia occurs via GluR2-sites in which a switching from GluR2-containing Ca
2+-impermeable receptors to GluR2-lacking Ca 2+ -permeable subtypes constitutes an important step. Interestingly attention regarding excitotoxicity-related ischemic events, aside being largely directed to the over activation of AMPARs, appears to be also focused on the activation of the caspase factors through the translocation of the pro-apoptotic B cell lymphoma 2-associated X protein (Bax) to the mitochondria. Although molecular brain mechanisms capable of repairing part of the neuronal damages and to restore the morpho-functional organization during ischemic episodes are well known, this disorder continues to attract much attention especially due to its elevated mortality feature. In this review we analyzed the role played by GluR2 AMPAR subunit in the pathological processes that lead to neurodegenerative diseases with great attention being paid to the assembly of the major synaptic AMPARs together with cellular events that feasibly account for ischemic brain damages. In this context, knowledge of the different molecular mechanisms operating under these conditions may surely provide helpful indications regarding the identification of new therapeutic targets for treating cerebral ischemia.